Ubinha, A.C.F.; Honorato, C.M.; Santos, M.H.d.; Filho, L.P.d.M.; Branquinho, L.I.; Longatto-Filho, A.; Reis, R.D.
The Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review. Cancers 2026, 18, 545.
https://doi.org/10.3390/cancers18040545
AMA Style
Ubinha ACF, Honorato CM, Santos MHd, Filho LPdM, Branquinho LI, Longatto-Filho A, Reis RD.
The Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review. Cancers. 2026; 18(4):545.
https://doi.org/10.3390/cancers18040545
Chicago/Turabian Style
Ubinha, Ana Carla Franco, Camila Musa Honorato, Marcelo Henrique dos Santos, Luis Pires de Melo Filho, Luciano Ipólito Branquinho, Adhemar Longatto-Filho, and Ricardo Dos Reis.
2026. "The Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review" Cancers 18, no. 4: 545.
https://doi.org/10.3390/cancers18040545
APA Style
Ubinha, A. C. F., Honorato, C. M., Santos, M. H. d., Filho, L. P. d. M., Branquinho, L. I., Longatto-Filho, A., & Reis, R. D.
(2026). The Impact of the Number of Neoadjuvant Chemotherapy Cycles on Outcomes in Advanced Ovarian Cancer: A Narrative Review. Cancers, 18(4), 545.
https://doi.org/10.3390/cancers18040545
